A black Maybach sedan smoothly drove into the Nandu High-tech Zone. The windows were tinted with deep anti-peep film, reflecting the modern buildings and green belts swiftly passing by on both sides of the road. Inside the car, Zhu Cheng set down the latest copy of the "Global dical Cost-Effectiveness Analysis Report on System Regulation Therapy and K Therapy," took off his gold-rimd glasses, and rubbed his brow.
At over forty years old, ti had not left many marks on his face, but instead, it had cultivated an elegant and capable deanor. His well-tailored dark gray custom suit, ticulous hairstyle, and the understated Patek Philippe on his wrist all attested to his current status and position—as the President of the international headquarters of the top health insurance company under Anning Group, with an annual salary over a hundred million, managing a health insurance fund pool worth hundreds of billions of dollars.
The car stopped at the entrance of Ruixing dical Building. The assistant quickly got out to open the car door for him. Zhu Cheng nodded slightly, stepped out, and looked up at the towering glass-walled building ahead, his eyes complex.
"President Zhu, Mr. Huang Jiacai from Ruixing dical is already waiting in the eting room," the assistant whispered.
"Good." Zhu Cheng withdrew his gaze, resud the composure of a business elite, and walked into the building under the guidance of Ruixing staff. His return to the country was not just for family visits; the most important business was to negotiate with Ruixing dical and the Sanbo Research Institute behind it to include the System Regulation Therapy and its flagship application, the K Therapy, into the reimbursent directory of the "Global Health Protection" high-end dical insurance. This was not only a business cooperation but an important strategic layout based on his professional judgnt for the company’s future.
The eting was held in the top-floor eting room of Ruixing. Huang Jiacai personally received him, and both teams conducted in-depth and efficient discussions on the core concepts, efficacy data, cost structure, risk control, and potential new therapies derived in the future from System Regulation Therapy. Zhu Cheng’s profound understanding of dical expertise, and his keen grasp of insurance actuarial and risk control, left a strong impression on Huang Jiacai.
"President Zhu is indeed an expert who gets straight to the point," Huang Jiacai praised, "Incorporating such highly individualized, dynamically processed therapies like system regulation into the standard insurance frawork indeed faces many challenges. But as you said, its potential to fundantally adjust the system, reducing long-term complications and recurrence risks, may be more cost-effective in the long run and aligns more with the trending evolution of the insurance philosophy ’prevention over cure.’
Zhu Cheng smiled, "President Huang overpraises, I’m just thinking from both the user’s and payer’s dual perspectives. System regulation will undoubtedly be the new model of future dicine, and Anning ’Global Health Protection’ is willing to be the first to take the plunge."
Preliminary cooperation intentions were smoothly reached. Both parties agreed that their respective teams would further refine the plan, especially the assessnt standards and fee settlent chanisms for different diseases and different stages.
After the eting, Huang Jiacai personally escorted Zhu Cheng to the elevator. Before parting, Zhu Cheng suddenly asked, "President Huang, may I ask if Professor Yang Ping is at the institute today? If convenient, I would like to visit in a personal capacity."
Huang Jiacai pondered briefly, communicated with Sanbo, and then smiled, "Professor Yang just finished a case discussion and is now available. He heard about your return and is very eager to see you."
"Thank you." Zhu Cheng nodded.
Half an hour later, Zhu Cheng’s car drove into the relatively understated and serene Sanbo Research Institute. Compared to the modern business atmosphere of Ruixing Building, this place, with greenery all around, had a more tranquil academic focus.
Led by Tang Shun, Zhu Cheng entered Yang Ping’s office. The room was spacious and bright, simply furnished, with the most striking feature being a bookshelf occupying almost an entire wall, filled with professional books and literature, alongside several lush green plants in the corner.
"Professor Yang, long ti no see." Zhu Cheng offered his hand proactively, with sincere tone.
Yang Ping shook his hand, calmly observing this forr peer and now insurance giant executive. "Mr. Zhu, please have a seat. President Huang ntioned that you have insights on incorporating system regulation therapy into insurance."
"I dare not call them insights in your presence, just so thoughts from another angle." Zhu Cheng sat on the sofa, relaxed yet respectful, "I’ve reviewed many K Therapy, especially cases like Sisi’s cured late-stage tumor patient data—truly astonishing. It’s not just curing a disease but changing the destiny trajectory of a person, a family. From an insurance perspective, this is priceless. But how to transform this ’priceless’ aspect into a sustainable paynt model is a challenge."
The two did not engage in much small talk, diving directly into the subject. Zhu Cheng displayed so of the analysis models he brought, discussing the possibility of setting paynt nodes according to different disease stages and regulation targets. Yang Ping explained, from the perspective of dical practice, the complexity and dynamic nature of the system regulation, emphasizing the difficulty of balancing standardized assessnt and individualized flexible adjustnt.
"We might need a ’frawork contract plus dynamic regulation’ model," Zhu Cheng thought aloud, "to set core paynt standards, but also leave a certain ’expert judgnt floating space,’ with a special committee to decide the paynt reasonableness for special cases. Of course, this requires a high level of trust and transparency."
Yang Ping nodded, "Trust is the foundation, data transparency is the key. All our treatnt processes and data are traceable on the platform, perhaps this can be the foundation to establish such trust and transparency."
User Comments
0 comments from readers